Summary of findings for exercise plus education vs control
Economic outcomes · people with Parkinson's disease
1 finding from 1 review
- no estimate extracted1 study · 133 participantsVery low
Findings
What do systematic reviews say?
1,166 questions · 1,249 findings · 76 reviews
No studies found 378 · 30.3%GRADE not reported 61 · 4.9%Very low 377 · 30.2%Low 284 · 22.7%Moderate 120 · 9.6%High 29 · 2.3%
Summary of Findings Table ‐ The Lidcombe Program vs waiting list control
Stuttering frequency (% SS) · children aged six years and younger who stutter
1 finding from 1 review
- Non‐pharmacological interventions for stuttering in children six years and younger 2021 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 151 participantsVery low
Summary of Findings Table ‐ The Lidcombe Program vs waiting list control
Stuttering severity · children aged six years and younger who stutter
1 finding from 1 review
- Non‐pharmacological interventions for stuttering in children six years and younger 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Summary of Findings Table ‐ The Lidcombe Program vs waiting list control
Speech efficiency (syllables per second) · children aged six years and younger who stutter
1 finding from 1 review
- Non‐pharmacological interventions for stuttering in children six years and younger 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 46 participantsModerate
Summary of Findings Table ‐ The Lidcombe Program vs waiting list control
Communication attitudes · children aged six years and younger who stutter
1 finding from 1 review
- Non‐pharmacological interventions for stuttering in children six years and younger 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Summary of Findings Table ‐ The Lidcombe Program vs waiting list control
Adverse effects · children aged six years and younger who stutter
1 finding from 1 review
- Non‐pharmacological interventions for stuttering in children six years and younger 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Summary of findings table ‐ Kappa‐opioid agonists vs placebo
Pruritus · patients with chronic kidney disease (CKD) pruritus
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 1292 participantsHigh
Summary of findings table ‐ Kappa‐opioid agonists vs placebo
Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Kappa‐opioid agonists vs placebo
Patient satisfaction ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Kappa‐opioid agonists vs placebo
Depression ‐ not measured · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Kappa‐opioid agonists vs placebo
Risk for at least one adverse drug reaction (ADR) per participant · patients with chronic kidney disease (CKD) pruritus
Summary of findings table ‐ Kappa‐opioid agonists may leads to higher risk for at least one adverse drug reaction (ADR) per patient compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyRR 1.73 [1.2, 2.48]5 studies · 1344 participantsLow
Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate
Hospital stay — not reported · patients requiring haemodialysis
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate
Dialysis dysequilibrium syndrome · patients requiring haemodialysis
It is very uncertain whether summary of findings table ‐ High sodium dialysate changes dialysis dysequilibrium syndrome compared with standard sodium dialysate (very low certainty).
1 finding from 1 review
- Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes onlyRR 0.07 [0, 1.12]1 study · 22 participantsVery low
Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate
Severe dialysis dysequilibrium syndrome · patients requiring haemodialysis
It is very uncertain whether summary of findings table ‐ High sodium dialysate changes severe dialysis dysequilibrium syndrome compared with standard sodium dialysate (very low certainty).
1 finding from 1 review
- Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes onlyRR 0.47 [0.02, 10.32]1 study · 22 participantsVery low
Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate
Death · patients requiring haemodialysis
1 finding from 1 review
- Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 22 participantsVery low
Summary of findings table ‐ High sodium dialysate vs standard sodium dialysate
Adverse events · patients requiring haemodialysis
It is very uncertain whether summary of findings table ‐ High sodium dialysate changes adverse events compared with standard sodium dialysate (very low certainty).
1 finding from 1 review
- Interventions for preventing haemodialysis dysequilibrium syndrome 2024 · Cochrane Headline outcomes onlyRR 0.29 [0.08, 1.02]1 study · 22 participantsVery low
Summary of findings for cholinesterase inhibitors vs placebo
Rate of adverse events excluding falls (per person year) · people with Parkinson's disease
Summary of findings for cholinesterase inhibitors may leads to higher rate of adverse events excluding falls (per person year) compared with placebo (low certainty).
1 finding from 1 review
- Rate ratio 1.6 [1.28, 2.01]2 studies · 175 participantsLow
Summary of findings for cholinesterase inhibitors vs placebo
Economic outcomes · people with Parkinson's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings for cholinesterase inhibitors vs placebo
Falls · people with Parkinson's disease
Summary of findings for cholinesterase inhibitors may leads to lower rate of falls (falls per person‐year) compared with placebo (low certainty).
1 finding from 1 review
- Rate ratio 0.5 [0.44, 0.58]3 studies · 229 participantsLow
Summary of findings for cholinesterase inhibitors vs placebo
Number of people who experienced one or more falls · people with Parkinson's disease
1 finding from 1 review
- no estimate extracted3 studies · 230 participantsVery low